Kore Private Wealth LLC Cerus Corp Transaction History

Kore Private Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$5.78 - $7.47 $7,514 - $9,711	-1,300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.84 - $4.86 $4,992 - $6,318	1,300 New	1,300 $5,000
Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $5,863 - $8,580	-1,300 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$4.89 - $7.16 $6,357 - $9,308	1,300 New	1,300 $7,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $294M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.